These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19432589)

  • 1. Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor.
    Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Moro F; Pagliaro P; Alloatti G
    Acta Physiol (Oxf); 2009 Nov; 197(3):175-85. PubMed ID: 19432589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
    Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.
    Penna C; Alloatti G; Cappello S; Gattullo D; Berta G; Mognetti B; Losano G; Pagliaro P
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2512-20. PubMed ID: 15637120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
    Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling.
    Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Pagliaro P; Alloatti G
    J Physiol Pharmacol; 2008 Mar; 59(1):47-54. PubMed ID: 18441387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
    Park SS; Zhao H; Mueller RA; Xu Z
    J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
    Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
    Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
    Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
    Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
    Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
    J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.